Jean-Marc de Muys

Mechanism of Action and In Vitro Activity of 1′,3′-Dioxolanylpurine Nucleoside Analogues against Sensitive and Drug-Resistant Human Immunodeficiency Virus Type 1 Variants

Zhengxian Gu, Mark A. Wainberg, Nghe Nguyen‐Ba et al. · Antimicrobial Agents and Chemotherapy · 1999 · 69 citations · Full text

Medicine, Medicinal Chemistry, Pharmacology +14

The synthesis of Streptococcus pneumoniae polysaccharide-tetanus toxoid conjugates and the effect of chain length on immunogenicity

Craig A. Laferrière, Ramesh Sood, Jean-Marc de Muys et al. · Vaccine · 1997 · 65 citations

Life Sciences, Immunology, Microbiology +14

<i>Streptococcus pneumoniae</i>Type 14 Polysaccharide-Conjugate Vaccines: Length Stabilization of Opsonophagocytic Conformational Polysaccharide Epitopes

Craig A. Laferrière, Ramesh Sood, Jean-Marc de Muys et al. · Infection and Immunity · 1998 · 57 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Anti-Human Immunodeficiency Virus Type 1 Activity, Intracellular Metabolism, and Pharmacokinetic Evaluation of 2′-Deoxy-3′-Oxa-4′-Thiocytidine

Jean-Marc de Muys, Henriette Gourdeau, Nghe Nguyen‐Ba et al. · Antimicrobial Agents and Chemotherapy · 1999 · 56 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +16

Synthesis and in vitro cytotoxicity of cryptophycins and related analogs

Jean-Marc de Muys, Rabindra Rej, Dieu Nguyen et al. · Bioorganic & Medicinal Chemistry Letters · 1996 · 21 citations

Pharmacy, Medicinal Chemistry, Toxicology +5